Ray Dalio’s Moderna MRNA Stock Holding History

Ray Dalio’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.8M	Buy	74,822 +59,641	+393%	+$2.78M	0.02%	484
2025 Q4	$448K	Sell	15,181 -207,029	-93%	-$5.62M	﹤0.01%	981
2025 Q3	$5.74M	Buy	+222,210	New	+$6.2M	0.02%	463
2025 Q1	–	Sell	-605,782	Closed	-$25.2M	–	752
2024 Q4	$25.2M	Buy	+605,782	New	+$29M	0.12%	140
2024 Q3	–	Sell	-15,309	Closed	-$1.82M	–	867
2024 Q2	$1.82M	Buy	+15,309	New	+$1.94M	0.01%	552
2023 Q3	–	Sell	-30,865	Closed	-$3.75M	–	788
2023 Q2	$3.75M	Buy	30,865 +25,489	+474%	+$3.4M	0.02%	357
2023 Q1	$826K	Sell	5,376 -2,301	-30%	-$380K	0.01%	581
2022 Q4	$1.38M	Sell	7,677 -9,758	-56%	-$1.6M	0.01%	593
2022 Q3	$2.06M	Sell	17,435 -231,722	-93%	-$35.2M	0.01%	557
2022 Q2	$35.6M	Buy	249,157 +202,476	+434%	+$28.9M	0.15%	133
2022 Q1	$8.04M	Buy	46,681 +43,042	+1,183%	+$7.25M	0.03%	342
2021 Q4	$924K	Sell	3,639 -4,670	-56%	-$1.37M	0.01%	589
2021 Q3	$3.2M	Buy	+8,309	New	+$3.06M	0.02%	362

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ray Dalio's MRNA Position: Q1 2026 in Review

Ray Dalio increased its Moderna (MRNA) stake by 393% in Q1 2026, buying an estimated $2.78M and bringing the position to 74,822 shares worth $3.8M. The position accounts for 0.02% of the portfolio, ranked #484.

Ray Dalio first reported a position in MRNA in Q3 2021 and has held it in 13 quarters since. The position peaked at $35.6M in Q2 2022. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Ray Dalio held 74,822 shares of Moderna worth $3.8M as of Q1 2026.
Ray Dalio bought 59,641 Moderna shares in Q1 2026, an estimated $2.78M.
Moderna made up 0.02% of Ray Dalio's portfolio in Q1 2026, its #484 holding.
Ray Dalio first reported a position in Moderna in Q3 2021 and has held it in 13 quarters since.
Ray Dalio's Moderna position peaked at $35.6M in Q2 2022.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.